Slotervaart Hospital Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Amsterdam Netherlands (2018)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Slotervaart Hospital

Active Ingredients

Drugs in Phase 4 Trials (3)

dapagliflozin (farxiga) (1 trial)

insulin human (humulin) (2 trials)

maraviroc (selzentry) (1 trial)

Drugs in Phase 3 Trials (2)

amphotericin b (fungizone) (1 trial)

miltefosine (impavido) (1 trial)

Drugs in Phase 2 Trials (1)

boceprevir (victrelis) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

Hepatitis C (Phase 2)

HIV Infections (Phase 4)

HIV Seropositivity (Phase 3)

Hyperglycemia (Phase 4)

Leishmaniasis (Phase 3)

Leishmaniasis, Visceral (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 6